Search research articles
Contact Us
Filters
Showing results (31-40 of 82) with videos related to
Page
of 9
Sort By:
United European Gastroenterology Journal
|
August 18, 2017
Bacterial stimuli activate nitric oxide colonic mucosal production in diverticular disease. Protective effects of <i>L. casei DG</i>® (<i>Lactobacillus paracasei</i> CNCM I-1572)
Fabio Turco, Paolo Andreozzi, Ilaria Palumbo, et al.
Cells
|
February 15, 2022
New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond
Alessandro Audisio, Consuelo Buttigliero, Marco Donatello Delcuratolo, et al.
Endocrine-Related Cancer
|
May 5, 2021
Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC
Fabio Turco, Marcello Tucci, Rosario Francesco Di Stefano, et al.
Cells
|
March 10, 2022
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside
Antonio Ungaro, Marcello Tucci, Alessandro Audisio, et al.
Journal of Clinical Medicine
|
January 23, 2024
Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma
Alessandro Samuelly, Rosario Francesco Di Stefano, Fabio Turco, et al.
Cancer Treatment Reviews
|
May 9, 2024
Treatment options in first-line metastatic renal carcinoma: A meta-analysis of 2556 patients treated with immune checkpoint inhibitors-based combinations in randomised controlled trials
Marcello Tucci, Marta Mandarà, Jacopo Giuliani, et al.
Critical Reviews in Oncology/Hematology
|
June 2, 2020
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives
Gianmarco Leone, Consuelo Buttigliero, Chiara Pisano, et al.
Cells
|
August 28, 2024
Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis
Giovanni Farinea, Mariangela Calabrese, Federica Carfì, et al.
Prostate Cancer and Prostatic Diseases
|
December 14, 2023
Safety profile of darolutamide versus placebo: a systematic review and meta-analysis
Fabio Turco, Silke Gillessen, Giorgio Treglia, et al.
Prostate Cancer and Prostatic Diseases
|
February 19, 2021
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate
Rosario F Di Stefano, Marcello Tucci, Fabio Turco, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 82) with videos related to
Sort By:
Page
of 9
United European Gastroenterology Journal
|
August 18, 2017
Bacterial stimuli activate nitric oxide colonic mucosal production in diverticular disease. Protective effects of <i>L. casei DG</i>® (<i>Lactobacillus paracasei</i> CNCM I-1572)
Fabio Turco, Paolo Andreozzi, Ilaria Palumbo, et al.
Cells
|
February 15, 2022
New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond
Alessandro Audisio, Consuelo Buttigliero, Marco Donatello Delcuratolo, et al.
Endocrine-Related Cancer
|
May 5, 2021
Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC
Fabio Turco, Marcello Tucci, Rosario Francesco Di Stefano, et al.
Cells
|
March 10, 2022
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside
Antonio Ungaro, Marcello Tucci, Alessandro Audisio, et al.
Journal of Clinical Medicine
|
January 23, 2024
Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma
Alessandro Samuelly, Rosario Francesco Di Stefano, Fabio Turco, et al.
Cancer Treatment Reviews
|
May 9, 2024
Treatment options in first-line metastatic renal carcinoma: A meta-analysis of 2556 patients treated with immune checkpoint inhibitors-based combinations in randomised controlled trials
Marcello Tucci, Marta Mandarà, Jacopo Giuliani, et al.
Critical Reviews in Oncology/Hematology
|
June 2, 2020
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives
Gianmarco Leone, Consuelo Buttigliero, Chiara Pisano, et al.
Cells
|
August 28, 2024
Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis
Giovanni Farinea, Mariangela Calabrese, Federica Carfì, et al.
Prostate Cancer and Prostatic Diseases
|
December 14, 2023
Safety profile of darolutamide versus placebo: a systematic review and meta-analysis
Fabio Turco, Silke Gillessen, Giorgio Treglia, et al.
Prostate Cancer and Prostatic Diseases
|
February 19, 2021
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate
Rosario F Di Stefano, Marcello Tucci, Fabio Turco, et al.
Page
of 9